Rare diseases
Investigational molecules
Locations
Back to Hungary68 clinical trials in Veszprem, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis
HungaryStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
HungaryBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
HungaryEfficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial
HungaryStudy of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis
HungaryStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
HungaryComparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment
HungaryStudy on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
HungaryStudy on Guselkumab for Treating Active Psoriatic Arthritis in Patients with Inadequate Response to One Prior Anti-TNF Agent
HungaryStudy of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis
HungaryStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
HungaryHungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for moderate to severe plaque psoriasis, including investigations of innovative therapies like JNJ-77242113 and ESK-001.
Multiple trials focusing on efficacy assessment and treatment response durability.
Extensive research into psoriatic arthritis treatments, including trials with zasocitinib, sonelokimab, and deucravacitinib for both biologic-naïve and experienced patients.
Focus on reducing symptoms and improving quality of life for patients.
Innovative research targeting systemic lupus erythematosus and other inflammatory conditions, with studies on medications like GLPG3667 and upadacitinib.
Comprehensive evaluation of disease activity and treatment responses.
Studies examining treatments for knee osteoarthritis, including comparative analysis of different chondroitin sulfate formulations and novel compounds.
Focus on both symptom management and functional outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
